NDC 63629-7125

buprenorphine hydrochloride

Buprenorphine Hydrochloride

buprenorphine hydrochloride is a Sublingual Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Buprenorphine Hydrochloride.

Product ID63629-7125_047cf3bf-65d9-4d3e-aaaa-4f5c5c9364a2
NDC63629-7125
Product TypeHuman Prescription Drug
Proprietary Namebuprenorphine hydrochloride
Generic NameBuprenorphine Hydrochloride
Dosage FormTablet
Route of AdministrationSUBLINGUAL
Marketing Start Date2010-09-24
Marketing CategoryANDA /
Application NumberANDA090622
Labeler NameBryant Ranch Prepack
Substance NameBUPRENORPHINE HYDROCHLORIDE
Active Ingredient Strength2 mg/1
Pharm ClassesPartial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA ScheduleCIII
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63629-7125-1

60 TABLET in 1 BOTTLE (63629-7125-1)
Marketing Start Date2016-10-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-7125-4 [63629712504]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

NDC 63629-7125-5 [63629712505]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

NDC 63629-7125-7 [63629712507]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

NDC 63629-7125-6 [63629712506]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

NDC 63629-7125-2 [63629712502]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

NDC 63629-7125-3 [63629712503]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

NDC 63629-7125-1 [63629712501]

buprenorphine hydrochloride TABLET
Marketing CategoryANDA
Application NumberANDA090622
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-28
Marketing End Date2018-02-28

Drug Details

NDC Crossover Matching brand name "buprenorphine hydrochloride" or generic name "Buprenorphine Hydrochloride"

NDCBrand NameGeneric Name
0143-9246Buprenorphine HydrochlorideBuprenorphine Hydrochloride
0409-2012Buprenorphine HydrochlorideBuprenorphine Hydrochloride
0517-0725Buprenorphine HydrochlorideBuprenorphine Hydrochloride
21695-515Buprenorphine HydrochlorideBuprenorphine Hydrochloride
35356-556buprenorphine hydrochloridebuprenorphine hydrochloride
42023-179Buprenorphine HydrochlorideBuprenorphine Hydrochloride
50090-1571buprenorphine hydrochloridebuprenorphine hydrochloride
50383-924buprenorphine hydrochloridebuprenorphine hydrochloride
50383-930buprenorphine hydrochloridebuprenorphine hydrochloride
53217-246buprenorphine hydrochloridebuprenorphine hydrochloride
70518-0442buprenorphine hydrochloridebuprenorphine hydrochloride
63629-4092Buprenorphine hydrochlorideBuprenorphine hydrochloride
63629-7126buprenorphine hydrochloridebuprenorphine hydrochloride
64725-1924buprenorphine hydrochloridebuprenorphine hydrochloride
64725-0930buprenorphine hydrochloridebuprenorphine hydrochloride
67046-991buprenorphine hydrochloridebuprenorphine hydrochloride
67046-990buprenorphine hydrochloridebuprenorphine hydrochloride
70518-2216buprenorphine hydrochloridebuprenorphine hydrochloride
55700-867BELBUCAbuprenorphine hydrochloride
12496-0757Buprenexbuprenorphine hydrochloride
50090-2924BuprenorphineBuprenorphine Hydrochloride
52440-100Probuphinebuprenorphine hydrochloride

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.